Position in DYN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,383,524
+$1,374,566 QoQ
Shares Held
242,392
+9.6% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. DYN ranks #61 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,383,524 | 242,392 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $4,008,958 | 221,123 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,835,324 | 196,080 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,592,457 | 125,886 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,033,576 | 318,653 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,322,765 | 317,664 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,671,840 | 70,961 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,683,103 | 46,857 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $1,201,271 | 34,040 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $768,743 | 27,078 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $277,982 | 20,901 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $191,949 | 21,423 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $195,660 | 17,392 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $224,835 | 19,517 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $213,256 | 18,400 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $180,225 | 14,191 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $97,890 | 14,249 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $157,218 | 16,309 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $216,956 | 18,247 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $280,513 | 17,273 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $375,143 | 17,830 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $149,119 | 9,602 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $249,564 | 11,884 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||